First Midwest Bank Trust Division’s AstraZeneca AZN Stock Holding History

First Midwest Bank Trust Division’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$248K	Buy	+2,127	New	+$250K	0.03%	340

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

First Midwest Bank Trust Division's AZN Position: Q4 2021 in Review

First Midwest Bank Trust Division opened a new position in AstraZeneca (AZN) in Q4 2021: 2,127 shares worth $248K. The stake represents 0.03% of the portfolio and ranks #340 among its holdings.

949 funds tracked by Wall St. Rank hold AZN as of Q4 2021.

First Midwest Bank Trust Division held 2,127 shares of AstraZeneca worth $248K as of Q4 2021.
AstraZeneca was a new First Midwest Bank Trust Division position in Q4 2021.
AstraZeneca made up 0.03% of First Midwest Bank Trust Division's portfolio in Q4 2021, its #340 holding.
949 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2021, filed 18 Jan 2022.